Sarcopenia Screening in Elderly Individuals

Sponsor
Kırıkkale University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06012422
Collaborator
(none)
843
1
4

Study Details

Study Description

Brief Summary

In this study, it is aimed to evaluate parameters such as sarcopenia screening, muscle mass measurement, loss of strength that may develop due to sarcopenia, loss of balance and related fall, decrease in functionality, fragility and decreased physical activity in individuals aged 65 years and older in Kırıkkale city center.

Condition or Disease Intervention/Treatment Phase
  • Other: evaluation group
N/A

Detailed Description

Although aging occurs in all periods in the human body, physical, mental and physical aging becomes visible as you get older. This situation is caused by physiological aging, environmental factors, existing chronic diseases and related symptoms. Today, increasing life expectancy and aging population must be taken into account. Since the age-related symptoms of elderly individuals are compatible with the consequences of aging, they can be ignored as a natural process, and therefore its progression cannot be prevented. With our project, it is aimed that screening for sarcopenia will be an exemplary study throughout Turkey and this type of screening will be widespread. In addition, it is aimed to divide elderly individuals into groups as presarcopenia, sarcopenia and severe sarcopenia, and to provide necessary guidance, protective and prevention approaches, strengthening and exercise training.

Demographic data of elderly individuals (age, gender, height, weight, BMI (Body mass index will be obtained by dividing body weight (kg), height (m) squared) occupation, etc.), chronic diseases (hypertension, diabetes, chronic obstructive pulmonary disease) (COPD), rheumatic diseases), drugs used, smoking, alcohol habits, and assistive device use, and the 'Clinical Vulnerability Scale' to evaluate the cognitive status of individuals through the 'Mini Nutritional Assessment form (MNA)'. 'Standardized Mini-Mental Test' to assess balance and walking, 'Tinetti balance and walking test' to evaluate balance and walking, 'Falling Risk Self-Assessment Scale' to assess falls, 'Functional Independence and Challenge Scale' to measure functional independence in activities of daily living. 'Short Physical Performance Test' (KFPT), Sarcopenia screening test (SA) to assess physical fitness RC-F), it is planned to use the Physical Activity Scale for the Elderly (PASE) to evaluate the level of physical activity, to use hand dynamometer, to evaluate muscle strength, and to measure the muscle mass of individuals with an inbody bioimpedance device.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
843 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
There is no randomization in our study, all elderly individuals who meet the inclusion and exclusion criteria will be evaluated.There is no randomization in our study, all elderly individuals who meet the inclusion and exclusion criteria will be evaluated.
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Sarcopenia Screening in Elderly Individuals Living in Kirikkale Province
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Individuals aged 65 and over who were screened for sarcopenia

Persons aged 65 and over will be evaluated only once and the assessment will be made through a face-to-face interview.

Other: evaluation group
Elderly individuals will be evaluated once, by face-to-face interview method.

Outcome Measures

Primary Outcome Measures

  1. Bioimpedance Analysis [day 1]

    used to measure muscle mass in epidemiological studies.A muscle mass index of less than 5.5 in women and less than 7 in men is associated with the risk of sarcopenia.

Secondary Outcome Measures

  1. Muscle Strength Evaluation [day 1]

    Handgrip strength is more commonly used, and low handgrip strength correlates better with impaired mobility and undesirable clinical outcomes than low muscle mass. In practice, a linear relationship was also found between basal handshake strength and dependence on activities of daily living. Therefore, hand grip strength measurement is a good and simple method to evaluate muscle strength.

  2. Short Physical Performance Test [day 1]

    The test measures parameters such as balance, sitting and standing from a chair and walking speed.All three physical performance measures (walking speed, balance, getting up from a chair) are scored between 0-4 according to the duration of the activity, the scores of the three tests are summed to give a total score between 0 (poor) and 12 (very good).

  3. SARC-F [day 1]

    Used for rapid diagnosis of sarcopenia.In the SARC-F questionnaire, information such as strength, walking without support, getting up from a chair/stool, climbing stairs and the number of falls in the last year are questioned (66). According to the EWGSOP2 guideline, a score of 4 or higher on the SARC-F questionnaire is considered significant in terms of sarcopenia.

  4. Mini Nutritional Assessment [day 1]

    The long MNA contains 18 items collected in 4 chapters. These four parts; anthropometric assessment (BMI, weight, arm and calf circumferences); overall assessment (lifestyle, medication, mobility, depression and dementia symptoms); short nutritional assessment (number of meals, food and fluid intake, autonomy in nutrition) and subjective assessment (self-perception of health and nutrition)

  5. Physical Activity Scale for the Elderly [day 1]

    The questionnaire evaluates the physical activities of the bereaved individuals in the last week and includes the components of leisure time, housework and work-related physical activity. walking activity outside the home; mild, moderate and vigorous sports and recreational activities; Participation in leisure time activities, including muscle strengthening exercises, was recorded as never, rarely (1-2 days / week), sometimes (3-4 days / week), and often (5-7 days / week), while the duration of the activities was: 1 It is classified as less than 1 hour, 1-2 hours, 2-4 hours and more than 4 hours.

  6. Tinetti balance and walking test [day 1]

    assesses balance and walking.In the test, the walking score is a maximum of 12 points, the balance score is a maximum of 16 points, and a total of 28 points. Those who score twenty-six and below are considered to have a problem. Studies have shown that the risk of falling increases as the score decreases.

  7. Fall Risk Self-Assessment Scale [day 1]

    It is a scale that assesses the risk of falling in the elderly. It consists of 13 items assessing the risk of falling in the elderly. The answers are yes (1 point) and no (0 points), and individuals who get 4 points or more from the score are classified as having a high risk of falling.

  8. Anthropometric Measurements [day 1]

    Anthropometric measurements of middle arm muscle circumference and calf circumference have been shown to predict functionality, general health status, nutritional adequacy, and survival in the elderly. It has been reported that calf circumference of 31 cm or less, arm circumference of 23 cm or less in women, and 24 cm or less in men are associated with sarcopenia.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Individuals aged 65 and over

  • Their willingness to participate in the study

  • A score of 24 or higher on the Mini Mental State Test (MMDT)

Exclusion Criteria:
  • Individuals under the age of 65

  • Individuals who cannot communicate well

  • Elderly individuals who cannot walk independently, have any orthopedic or neurological problems

  • Individuals who do not want to participate in the study

  • Individuals not eligible for bioimpedance analysis (pregnant individuals with pacemakers).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Kırıkkale University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Seyma Akdagli, Master of Science Student, Kırıkkale University
ClinicalTrials.gov Identifier:
NCT06012422
Other Study ID Numbers:
  • KU-FTR-SA-01
First Posted:
Aug 25, 2023
Last Update Posted:
Aug 25, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Seyma Akdagli, Master of Science Student, Kırıkkale University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2023